Au, Trang H.
Willis, Connor
Reblin, Maija
Peters, Katherine B.
Nghiemphu, Phioanh Leia
Taylor, Jennie W.
Colman, Howard
Cohen, Adam L.
Ormond, D. Ryan
Chakravarti, Arnab
Willmarth, Nicole
Menon, Jyothi
Ma, Junjie
Bauer, Hillevi
Watanabe, Alexandre H.
Ulrich, Cornelia M.
Singh, Prianka
Marshall, Alexander
Korytowsky, Beata
Stenehjem, David
Brixner, Diana http://orcid.org/0000-0001-6637-6359
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 12 March 2021
Accepted: 20 August 2021
First Online: 11 September 2021
Change Date: 18 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00520-021-06691-y
Declarations
:
: The study was approved by the institutional review boards of all study centers involved in the study.
: Caregivers and patients gave written informed consent to participate in the study; patients had given broad consent previously to have access to their medical records, which were used in this study.
: All authors consented to publish this paper.
: Alexandre H. Watanabe, Nicole Willmarth, and Adam L. Cohen have no conflicts of interest.Maija Reblin has received grants from Bristol Myers Squibb.Phioanh Leia Nghiemphu has received grants from Genentech and Novartis.Junjie Ma was an employee of the University of Utah at the time this study was conducted, is currently employed by Amgen Inc., and has received grants from Bristol Myers Squibb.Jyothi Menon was an employee of the University of Utah at the time this study was conducted, and has received grants from Bristol Myers Squibb.D. Ryan Ormond has received research funding from Agios, the American Cancer Society, American Heart Association, and Medtronic and is currently employed by Amgen Inc.Katherine B. Peters received grant/research support from Bristol Myers Squibb.Jennie W. Taylor received grant support from AbbVie, Agios, and Bristol Myers Squibb.Howard Coleman reports personal fees from Adastra Pharmaceuticals, Bayer, Best Doctors/Teladoc, Forma Therapeutics, Karyopharm Therapeutics, Orbus, and Private Health.Beata Korytowsky was an employee and shareholder of Bristol Myers Squibb at the time of study.Alexander Marshall and Prianka Singh are employees of Bristol Myers Squibb.David Stenehjem reports grants from Bristol Myers Squibb, and personal fees from Bristol Myers Squibb, Dracen Pharmaceuticals, Iterion Pharmaceuticals, Molecular Templates, and Salarius Pharmaceuticals.